Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Pharmaceutical composition for treating autonomic nervous disorder, preparation method and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of dysfunction and autonomic nerves, applied in the field of medicine, can solve the problems of poor treatment effect of high school and western medicine, and achieve the effect of multiple indications, no side effects, and easy availability of medicinal materials
Inactive Publication Date: 2016-04-13
屈友初 +1
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] Autonomic dysfunction can also occur in a variety of diseases such as anxiety, depression, neurasthenia, diabetes, hyperthyroidism, perimenopausal syndrome, partial testosterone deficiency syndrome, after surgery, tumor radiotherapy, chemotherapy, and after experiencing various major burdens. After sexual psychological events, the incidence of this disease is relatively high, and the current treatment effect of traditional Chinese and Western medicine is not good.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0020] The pharmaceutical composition used for the treatment of autonomic nervous dysfunction of the present invention is composed of the following raw materials in weight ratio:
[0021] 4-6 parts of Coptidis, 4-6 parts of Polygala, 4-6 parts of Baiziren, 4-6 parts of Suanzaoren, 4-6 parts of Angelica, 4-6 parts of Epimedium, 8-12 parts of gallnut, 8 parts of Digupi -12 parts, 8-12 parts Anemarrhena, 8-12 parts woody fragrance, 8-12 parts red peony root, 8-12 parts Corydalis Corydalis, 8-12 parts Salvia miltiorrhiza, 8-12 parts Eucommia ulmoides, 8-12 parts Polygonatum, ginseng 8-12 parts, 10-20 parts of raw rehmannia, 15-25 parts of reed root, 15-25 parts of mulberry leaves, 25-35 parts of oysters.
[0022] The inventor found in 23 years of clinical application that the purpose of treating autonomic nervous dysfunction can be achieved by adjusting the dosage of the crude drug within the following weight ratio range:
[0023] 5 parts of Coptidis, 5 parts of Polygala, 5 parts...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the field of medicine, particularly relates to a medicinal composition for treating autonomic nerve dysfunction as well as a preparation method and uses thereof. The medicinal composition comprises the following raw materials in parts by weight: rhizome coptidis 4-6 parts, polygala root 4-6 parts, Platycladus orientalis seed 4-6 parts, Ziziphus jujuba (Semen Ziziphi Spinosae) 4-6 parts, Angelica sinensis 4-6 parts, Herba Epimedii 4-6 parts, Galla Chinensis 8-12 parts, Cortex Lycii 8-12 parts, Anemarrhena asphodeloides 8-12 parts, Aucklandia lappa 8-12 parts, Radix Paeoniae Rubra 8-12 parts, Corydalis yanhusuo 8-12 parts, Salvia miltiorrhiza 8-12 parts, Eucommia ulmoides 8-12 parts, Rhizoma Polygonati 8-12 parts, Panax ginseng 8-12 parts, Radix rehmanniae 10-20, Rhizoma Phragmitis 12-25, mulberry leaf 15-25, and oyster 25-35. The medicinal composition of the invention has the advantages of good safety, no toxicity, no significant adverse side effects, reliable curative effect, multiple indications, easily-accessible raw materials, simple preparation method, and so on, and can effectively treat autonomic nerves dysfunction caused by a number of reasons. According to clinical application observation of 23 years, more than 1,000 cases of patients are treated, and the effective rate is up to 90%. The invention provides a new medicament choice for publics.
Description
technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for treating autonomic nervous dysfunction, a preparation method and application thereof. Background technique [0002] Autonomic dysfunction refers to the area managed by the autonomic nervous system (the autonomic nervous center manages emotions, behavior, regulates body temperature, regulates water balance, regulates the secretion of oxytocin, regulates feeding behavior, regulates gastric acid secretion, regulates cardiovascular activity, regulates glandular The function of the pituitary gland, the regulation of respiratory function, etc., except for the relative independence of the center, a considerable part of its regulation is realized through the peripheral parts, such as the activities of viscera, cardiovascular system and glands, and its distribution area is the lacrimal gland , parotid, submandibular and sublingual glands, heart, bronchi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.